Product
Targeted therapy
1 clinical trial
4 indications
Indication
PneumonitisIndication
InterstitialIndication
ImmunotherapyIndication
Immune-related Adverse EventsClinical trial
A Single-cell Approach to Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint BlockadeStatus: Recruiting, Estimated PCD: 2024-01-31